Top News

• Replimune BLA Resubmission for Melanoma Therapy
• Roches Giredestrant Combo Shows Positive Phase 3 Data
• Cell, Gene Therapy Monitoring Guide Encouraging: Attorneys
• AdvaMed Proposes MAHA Pathway for Devices
• Summits Ivonescimab Outperforms Tislelizumab in Trial
• FDA Updates Rybelsus Label for CV Risk Reduction
• Kenvue Urges FDA to Reject Acetaminophen Petition
• FDA Drug Approval Trends Slipping: Financial Analysts